[go: up one dir, main page]

AU7051981A - Sulphated polysaccarides - Google Patents

Sulphated polysaccarides

Info

Publication number
AU7051981A
AU7051981A AU70519/81A AU7051981A AU7051981A AU 7051981 A AU7051981 A AU 7051981A AU 70519/81 A AU70519/81 A AU 70519/81A AU 7051981 A AU7051981 A AU 7051981A AU 7051981 A AU7051981 A AU 7051981A
Authority
AU
Australia
Prior art keywords
polysaccarides
sulphated
sulphated polysaccarides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU70519/81A
Other versions
AU535791B2 (en
Inventor
Jean Mardiguian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9241965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7051981(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU7051981A publication Critical patent/AU7051981A/en
Application granted granted Critical
Publication of AU535791B2 publication Critical patent/AU535791B2/en
Assigned to RHONE-POULENC RORER S.A. reassignment RHONE-POULENC RORER S.A. Alteration of Name(s) in Register under S187 Assignors: PHARMINDUSTRIE
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AU70519/81A 1980-05-14 1981-05-13 Sulphated polysaccarides Expired AU535791B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8010791A FR2482611B1 (en) 1980-05-14 1980-05-14 NOVEL SULFATED POLYSACCHARIDES, METHODS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
FR8010791 1980-05-14

Publications (2)

Publication Number Publication Date
AU7051981A true AU7051981A (en) 1981-11-19
AU535791B2 AU535791B2 (en) 1984-04-05

Family

ID=9241965

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70519/81A Expired AU535791B2 (en) 1980-05-14 1981-05-13 Sulphated polysaccarides

Country Status (23)

Country Link
EP (1) EP0040144B1 (en)
JP (1) JPS6051482B2 (en)
KR (1) KR840001753B1 (en)
AR (1) AR229510A1 (en)
AT (1) AT384428B (en)
AU (1) AU535791B2 (en)
CA (1) CA1181744A (en)
DE (1) DE3165361D1 (en)
DK (1) DK168824B1 (en)
DZ (1) DZ294A1 (en)
ES (1) ES8206555A1 (en)
FI (1) FI67865C (en)
FR (1) FR2482611B1 (en)
GR (1) GR82283B (en)
HU (1) HU188667B (en)
IE (1) IE51283B1 (en)
IL (1) IL62866A (en)
IN (1) IN152828B (en)
MA (1) MA19143A1 (en)
NO (1) NO156129C (en)
NZ (1) NZ197081A (en)
PT (1) PT73024B (en)
ZA (1) ZA813176B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040081A1 (en) * 1997-03-11 1998-09-17 The Australian National University Sulfated oligosaccharides having anticoagulant/antithrombotic activity
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
US8003623B2 (en) 2002-10-10 2011-08-23 Aventis Pharma S.A. Mixtures of sulfated oligosaccharides

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548672A1 (en) * 1983-07-04 1985-01-11 Pharmuka Lab SULPHATE OLIGOSACCHARIDES AND THEIR USE AS MEDICAMENTS
DE3422407A1 (en) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen USE OF HEPARINE DERIVATIVES FOR SELECTIVE EXTRA-CORPORAL PRECIPITATION OF LOW-DENSITY-LIPOPROTEINS FROM FULL SERUM OR PLASMA
FR2584728B1 (en) * 1985-07-12 1987-11-20 Choay Sa PROCESS FOR THE SULFATION OF GLYCOSAMINOGLYCANS AND THEIR FRAGMENTS
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
ES2003197A6 (en) * 1987-01-05 1988-10-16 Rovi Lab Farmaceut Sa Process for the depolymerization of heparin for obtaining heparin with a low molecular weight and having an antithrombotic activity.
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1230582B (en) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi DERMATAN SULPHATE AND HEPARIN OILGOSACCHARID WITH ANTI-THEROSCLEROTIC ACTIVITIES
IT1234826B (en) * 1989-01-30 1992-05-29 Alfa Wassermann Spa HEPARIN DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
FR2663639B1 (en) * 1990-06-26 1994-03-18 Rhone Poulenc Sante LOW MOLECULAR WEIGHT POLYSACCHARIDE BLENDS PROCESS FOR PREPARATION AND USE.
USRE38743E1 (en) * 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
DE4121115B9 (en) * 1990-06-26 2005-09-29 Aventis Pharma S.A. Mixtures of sulfated polysaccharides with the basic structure of heparin-forming polysaccharides and low molecular weight, their method of preparation and use
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
IT1256236B (en) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl OLIGOSACCHARIDES WITH BIOLOGICAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION OF GLYCOSAMINOGLICANS
ES2077533B1 (en) * 1994-02-28 1996-07-01 Bioiberica PROCEDURE FOR OBTAINING OLIGOSACCHARIDE FRACTIONS BY CHEMICAL DEPOLYMERIZATION OF HEPARIN.
SI0946185T2 (en) * 1996-11-27 2010-08-31 Aventis Pharma Inc PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
JP4897991B2 (en) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ Ultra low molecular weight heparin composition
FR2811992B1 (en) * 2000-07-21 2003-07-04 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE356150T1 (en) * 2002-06-20 2007-03-15 Chemi Spa METHOD FOR PRODUCING HEPARINE ESTERS
FR2845686B1 (en) * 2002-10-10 2013-08-30 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2006096668A (en) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd A pharmaceutical comprising a combination of an elastase inhibitor and a blood coagulation system and / or fibrinolytic enzyme inhibitor
DE10260958A1 (en) * 2002-12-20 2004-07-08 Sustech Gmbh & Co. Kg Composite materials made from calcium compounds and polysaccharides containing glucuronic acid and / or iduronic acid
ITMI20031679A1 (en) * 2003-08-29 2005-02-28 Opocrin Spa PROCESS FOR THE PRODUCTION OF LOW WEIGHT EPARINES
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20050261241A1 (en) 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
ATE552004T1 (en) 2005-11-30 2012-04-15 Istituto G Ronzoni ORAL HEPARINE DERIVATIVES
ES2340902B1 (en) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. PHARMACEUTICAL COMPOSITION WITH GLYCAMINOGLYGANS AND ITS USE IN THE TREATMENT OF CHRONIC ULCERAS.
KR102082276B1 (en) * 2010-09-14 2020-02-27 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 High purity heparin and production method therefor
AU2018385557B2 (en) 2017-12-11 2024-01-04 Biological E Limited Process for the preparation of low molecular weight heparin
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
MX2022000343A (en) 2019-07-09 2022-03-11 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides.
CN114072430B (en) * 2020-04-27 2023-07-28 罗威制药股份有限公司 Low molecular weight heparin acquisition procedure and low molecular weight heparin obtained

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835112A (en) * 1970-06-08 1974-09-10 Etude Et D Exploit De Marques Heparin esters
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040081A1 (en) * 1997-03-11 1998-09-17 The Australian National University Sulfated oligosaccharides having anticoagulant/antithrombotic activity
US6271215B1 (en) 1997-03-11 2001-08-07 The Australian National University Sulfated oligosaccharides having anticoagulant/antithrombotic activity
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7812007B2 (en) 2000-07-21 2010-10-12 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US8003623B2 (en) 2002-10-10 2011-08-23 Aventis Pharma S.A. Mixtures of sulfated oligosaccharides
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GR82283B (en) 1984-12-13
AR229510A1 (en) 1983-09-15
CA1181744A (en) 1985-01-29
AT384428B (en) 1987-11-10
DK168824B1 (en) 1994-06-20
DK211981A (en) 1981-11-15
PT73024A (en) 1981-06-01
ES502199A0 (en) 1982-08-16
NZ197081A (en) 1984-07-31
EP0040144B1 (en) 1984-08-08
DE3165361D1 (en) 1984-09-13
DZ294A1 (en) 2004-09-13
KR840001753B1 (en) 1984-10-19
JPS6051482B2 (en) 1985-11-14
NO156129C (en) 1987-07-29
FR2482611B1 (en) 1986-03-07
ATA213681A (en) 1987-04-15
IL62866A (en) 1984-06-29
ES8206555A1 (en) 1982-08-16
IE811074L (en) 1981-11-14
MA19143A1 (en) 1981-12-31
KR830006333A (en) 1983-09-24
NO811632L (en) 1981-11-16
EP0040144A1 (en) 1981-11-18
FI67865B (en) 1985-02-28
FI67865C (en) 1985-06-10
IE51283B1 (en) 1986-11-26
IL62866A0 (en) 1981-07-31
HUT34769A (en) 1985-04-28
NO156129B (en) 1987-04-21
IN152828B (en) 1984-04-14
ZA813176B (en) 1982-05-26
PT73024B (en) 1982-07-01
HU188667B (en) 1986-05-28
FR2482611A1 (en) 1981-11-20
FI811469L (en) 1981-11-15
JPS5710601A (en) 1982-01-20
AU535791B2 (en) 1984-04-05

Similar Documents

Publication Publication Date Title
AU535791B2 (en) Sulphated polysaccarides
AU542145B2 (en) make
AU544099B2 (en) Triazolylpentenols
AU537992B2 (en) Polusilanes
AU546858B2 (en) s
AU535792B2 (en) l
AU6594981A (en) Platinum-diamines
AU541995B2 (en) m
AU539968B2 (en) Polysilane
AU538782B2 (en) Triazoloquinoxalin-4-ones
AU536754B2 (en) Imidodisulfamides
AU548992B2 (en) 2-guanidno-4-heteroarylthiazoles
AU6591180A (en) Indoxylmaltodextrins
AU545397B2 (en) Cloches
AU527275B2 (en) Auto-diaphragm hemodialyser
AU541912B2 (en) 2-nitroimidazoles
AU549968B2 (en) Glycosylglucans
AU540787B2 (en) 4-indenyl-alkyl-piperidenes
AU534814B2 (en) Showstand
AU543520B2 (en) Kijanimicin
AU537073B2 (en) Haloacetanilide
AU538427B2 (en) Dichlorobenzoyl-3-phenylpyrazolines
AU540683B2 (en) Photocomposer
AU517843B2 (en) Guanylamidines
AU548141B2 (en) 1-phenyl-2-triazolyl-pent-gen-3-ols